BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 306851)

  • 1. [High-dose methotrexate/leucovorin adjuvant chemotherapy of osteogenic sarcoma: biochemical effects in DNA-synthesis of bone marrow cells (author's transl)].
    Sauer H; Wilmanns W
    Blut; 1978 Jun; 36(6):357-61. PubMed ID: 306851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
    Jaffe N; Paed D; Farber S; Traggis D; Geiser C; Kim BS; Das L; Frauenberger G; Djerassi I; Cassady JR
    Cancer; 1973 Jun; 31(6):1367-73. PubMed ID: 4541163
    [No Abstract]   [Full Text] [Related]  

  • 3. [High-dose methotrexate therapy in osteogenic sarcoma: plasma pharmakokinetics to predict toxicity (author's transl)].
    Janka GE; Wiesner H; Bidlingmaier F; Haas RJ
    Klin Wochenschr; 1979 Apr; 57(8):411-6. PubMed ID: 313478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of high-dose methotrexate with citrovorum factor "rescue" in the treatment of osteogenic sarcoma.
    Jaffe N; Traggis D; Cassady JR; Filler RM; Watts H; Frei E
    Int J Radiat Oncol Biol Phys; 1977; 2(3-4):261-6. PubMed ID: 301137
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma.
    Goorin A; Strother D; Poplack D; Letvak LA; George M; Link M
    Med Pediatr Oncol; 1995 Jun; 24(6):362-7. PubMed ID: 7715542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biochemistry of the citrovorum factor rescue effect in normal bone marrow cells after high-dose methotrexate.
    Sauer H; Schalhorn A; Wilmanns W
    Eur J Cancer (1965); 1979 Oct; 15(10):1203-9. PubMed ID: 316389
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
    Rosenburg SA; Chabner BA; Young RC; Seipp CA; Levine AS; Costa J; Hanson TA; Head GC; Simon RM
    Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Compatibility and toxicity of methotrexate in the treatment of bone tumors].
    Pongracz N; Kelaridis T; Ritschl P
    Arzneimittelforschung; 1987 Apr; 37(4):456-60. PubMed ID: 3496891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient neurological disturbances induced by the chemotherapy of high-dose methotrexate for osteogenic sarcoma.
    Kiu MC; Liaw CC; Yang TS; Lai GM; Hsi SN; Lu CS
    Anticancer Drugs; 1994 Aug; 5(4):480-2. PubMed ID: 7949255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
    Cotter SM; Parker LM
    Am J Vet Res; 1978 Dec; 39(12):1943-5. PubMed ID: 312044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
    Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
    Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical control of high-dose methotrexate/Leucovorin rescue therapy.
    Wilmanns W; Sauer H; Schalhorn A
    Recent Results Cancer Res; 1980; 74():42-9. PubMed ID: 6969415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The classic: recent advances in chemotherapy of metastatic osteogenic sarcoma. 1972.
    Jaffe N
    Clin Orthop Relat Res; 2005 Sep; 438():19-21. PubMed ID: 16131864
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.
    Jaffe N; Frei E; Traggis D; Bishop Y
    N Engl J Med; 1974 Nov; 291(19):994-7. PubMed ID: 4606174
    [No Abstract]   [Full Text] [Related]  

  • 16. The potential for an improved prognosis with chemotherapy in osteogenic sarcoma.
    Jaffe N
    Clin Orthop Relat Res; 1975; (113):111-8. PubMed ID: 1081438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the chemotherapy of metastatic osteogenic sarcoma. 1972.
    Jaffe N
    Clin Orthop Relat Res; 1991 Sep; (270):4-7. PubMed ID: 1884556
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy in osteogenic sarcoma.
    Tichler TE; Am YB; Brenner HJ
    Prog Clin Biol Res; 1982; 99():49-75. PubMed ID: 6983080
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
    Jaffe N
    Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate revisited.
    Frei E
    Med Pediatr Oncol; 1976; 2(3):227-41. PubMed ID: 790144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.